e. coli strain m17
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00194922)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e. coli strain m17
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00324532 | Phase 3 | May 1, 2006 | BioBalance Corporation, Hebrew University |
| NCT00194922 | Phase 2 | Aug 1, 2004 | BioBalance Corporation, Cornell University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioBalance Corporation | For profit | 2 | 1 | 2 | 2004 |
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1